Back | Next |
home / stock / nbio / nbio message board
Subject | By | Source | When |
---|---|---|---|
$NBIO is in a nice price range for accumulation. | BlazingStocks | investorshub | 09/20/2023 4:40:18 PM |
$NBIO still in buy territory on my chart. | gladeshawk | investorshub | 09/20/2023 4:14:01 PM |
$NBIO - Nascent recently regained its worldwide marketing | BlazingStocks | investorshub | 09/19/2023 6:57:07 PM |
It's trading half of its 10-day average volume | BlazingStocks | investorshub | 09/19/2023 4:10:01 PM |
$NBIO is an easy 10X mover from current | gladeshawk | investorshub | 09/19/2023 3:54:37 PM |
$NBIO is an easy 10X mover from current | gladeshawk | investorshub | 09/19/2023 3:54:30 PM |
Very informative article... so much great information and | BlazingStocks | investorshub | 09/19/2023 1:50:39 PM |
$NBIO Follow Up.. More Signs of Deep Value | jedijazz | investorshub | 09/19/2023 1:27:42 PM |
znewcar1: $NBIO 27% v510K c.1445 f124,485M Hod.149 ML.0531 | znewcar1 | investorshangout | 09/19/2023 2:48:04 AM |
PPS moving up. Phase 2 trials | gladeshawk | investorshub | 09/14/2023 4:28:11 PM |
Any good news on Phase 2 trials and | gladeshawk | investorshub | 08/31/2023 4:03:25 PM |
$NBIO .07 +14.66% making a huge move today | jedijazz | investorshub | 08/22/2023 6:12:09 PM |
$NBIO New HOD .065 +6.47% Nascent CEO, Sean | jedijazz | investorshub | 08/22/2023 4:46:29 PM |
$NBIO announced today that the Company has been | BlazingStocks | investorshub | 08/22/2023 4:33:14 PM |
$NBIO Nascent CEO, Sean Carrick, commented, this is | jedijazz | investorshub | 08/22/2023 3:01:20 PM |
Looking good on today's News... trading nearly 60% | BlazingStocks | investorshub | 08/22/2023 2:34:30 PM |
$NBIO .0635 +4.01% Up Early thin to .07's! | jedijazz | investorshub | 08/22/2023 1:41:24 PM |
$NBIO could gap up early. Level 2 Moving | jedijazz | investorshub | 08/22/2023 12:57:56 PM |
Another Step Closer $NBIO #FDA -PHASE II Clinical | jedijazz | investorshub | 08/22/2023 12:50:15 PM |
$NBIO News August 22, 2023 Nascent Biotech to Begin | BlazingStocks | investorshub | 08/22/2023 12:29:10 PM |
News, Short Squeeze, Breakout and More Instantly...
NORTH PALM BEACH, FL / ACCESSWIRE / April 16, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturin...
NORTH PALM BEACH, FL / ACCESSWIRE / March 19, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, and HypoSpray Pharma ("HypoSpray ® "), a clinical...
NORTH PALM BEACH, FL and NEW YORK, NY / ACCESSWIRE / February 6, 2024 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent"), a clinical-stage biotechnology company pioneering the development of monoclonal antibodies for the treatment of various cancers and viral infections, announc...